Drug Research

In a major concern surrounding Europe’s pharma industry, there is an anticipation that it could go on to lose out to elevated competition from emerging markets like China as well as the US when one talks of innovation and...

SK pharmteco, SK Inc.'s contract development manufacturing organization (CDMO) for pharmaceuticals, completed its second facility for cell and gen e therapies (CGT) manufacturing in Europe. With this milestone, SK pharmteco is rapidly expanding its presence in the global market. SK pharmteco...

Croda International Plc (Croda) announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. The first partnership is an exclusive license agreement with Amyris, a...

Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets. The LPS in vivo model supports...

An Innovate UK-backed biotech company has achieved a pioneering biocomputer breakthrough which is accelerating the development and manufacture of cheaper drugs and vaccines. BiologIC Technologies, inventor of the world’s first biocomputer, has developed 3D printed ‘lab-on-a-chip’ platforms - miniaturised devices...

The Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market is expected to see significant growth. Factors driving this include rising pharmaceutical demand, increased focus on research and development, and the outsourcing of drug development and manufacturing. The...

According to insights, the market for contract development and manufacturing organizations (CDMOs) specializing in small molecule innovation is estimated to reach a value of $48.09 billion in 2023 and $89.43 billion in 2033. The sales in this market are...